David M Engelhardt (David Engelhardt)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Spinal Cord Injury

Signaling Pathway

Top Venues

Genesis (New York, N.Y. : 2000)

WIREs mechanisms of disease

This page only lists publications with an associated author ORCID identifier.

Publications

David M Engelhardt, Amber Marean, David McKean, Juliette Petersen, Lee A Niswander
RSG1 is required for cilia-dependent neural tube closure. Genesis (New York, N.Y. : 2000) 62 (3) (2024)
David M Engelhardt, Amber Marean, David McKean, Juliette Petersen, Lee A Niswander
RSG1 is required for cilia-dependent neural tube closure. Genesis (New York, N.Y. : 2000) 62 (3) (2024)
David M Engelhardt, Amber Marean, David McKean, Juliette Petersen, Lee A Niswander
RSG1 is required for cilia-dependent neural tube closure. Genesis (New York, N.Y. : 2000) 62 (3) (2024)
David M Engelhardt, Amber Marean, David McKean, Juliette Petersen, Lee A Niswander
RSG1 is required for cilia-dependent neural tube closure. Genesis (New York, N.Y. : 2000) 62 (3) (2024)
David M Engelhardt, Cara A Martyr, Lee A Niswander
Pathogenesis of neural tube defects: The regulation and disruption of cellular processes underlying neural tube closure. WIREs mechanisms of disease 14 (5) (2022)